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Cystic Fibrosis (CF) is a common fatal disorder associated with mutations of recessive inheritance 
in the gene that encodes for the cystic fibrosis transmembrane regulator (CFTR) protein. In the 
past, the life expectancy of patients with CF was 6 months due to respiratory failure and 
gastrointestinal (GI) complications. However, with current advances in the treatment and 
management of the disease, the life expectancy of CF has improved drastically. As a consequence, 
now adult CF patients are exposed to previously unknown chronic complications of CF such a 
peripheral neuropathy. Initially, peripheral neuropathy was considered a consequence of 
malnutrition and vitamin E deficiency, however, later studies showed that CFTR is widely 
expressed in the nervous system and may be an important regulator of chloride homeostasis in 
neurons. Unfortunately, the role of CFTR in neurons and its relevance in CF neuropathology has 
not been studied in detail.  
Therefore, this project aimed to investigate the cellular consequences of the lack of CFTR function 
in dorsal root ganglion (DRG) neurons. First, we quantified chloride levels in DRG primary 
cultures from WT and CFTR-/- swine using a chloride sensitive dye (i.e., MQAE) and perforated 
patch-clamp electrophysiology. We found that CFTR-/- DRG neurons have a lower intracellular 
concentration of chloride compared to WT neurons. Second, we used a CFTR inhibitor (i.e., CFTR 
(inh)-172) and current-clamp electrophysiology to determine if short-term inhibition of CFTR had 
abnormal effects in DRG neuronal excitability and GABA mediated inhibition of action potentials. 
We observed that CFTR inhibition in DRG neurons had no effect on DRG neuronal excitability. 
Moreover, our findings indicate that GABA did not modulate action potential firing in DRG 
neurons from swine. Taken together, our data suggest that CFTR has an active role in the regulation 
of chloride transport in DRG neurons. However, if these changes have a significant effect on 
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1.1.Cystic Fibrosis (CF) 
Cystic Fibrosis (CF) is a multisystem disorder with genetic etiology predominantly associated 
with the progressive failure of the respiratory system (Donaldson & Boucher, 2006). The 
occurrence of CF varies widely according to ethnicity and geographic location, being more 
common in populations with northern European ancestry (Lubamba et al., 2012). There are more 
than 80,000 people worldwide and approximately 4,000 Canadians living with CF (Cystic Fibrosis 
Foundation, 2018; Lubamba et al., 2012). Moreover, in Canada, the clinical complications of CF 
account for a cumulative of 26,000 days expended in hospital, which affects the quality of life of 
CF patients and their caregivers, and can result in high medical care expenditures (Cystic Fibrosis 
Foundation, 2018). 
In 1938, Dorothy Andersen first described CF of the pancreas (Andersen, 1938). At that 
moment, the life expectancy of patients with CF was 6 months due to respiratory failure, meconium 
ileus, and malnutrition (Davis, 2006). However, with current advances in controlling lung 
infection, improving mucus clearance, and correcting CFTR function, most patients survive well 
into adulthood (Elborn, 2016). Indeed, the estimated median projected age of survival in Canada 
for CF patients is approximately 52.1 years (Cystic Fibrosis Canada, 2018). 
CF is caused by mutations of recessive inheritance that result in complete or partial dysfunction 
of the cystic fibrosis transmembrane regulator (CFTR) (Elborn, 2016). So far in humans, more 
than 2,000 variants of the CFTR channel have been described, and 360 mutations have been 
associated with the occurrence of CF, which prevents practical classification of the disease 
according to mutation type (Cutting et al., 2013; Elborn, 2016). Therefore, CF mutations are 
classified into five categories depending on their cellular phenotype. Mutations that affect 
transcription, processing, and gating of the channel (Class I, II, and III, respectively) usually result 
in a more severe form of the disease. In contrast, mutations that alter the conduction properties or 
reduce the number of functional channels at the membrane (Class IV and V, respectively) are 




1.1.1. CFTR  
The CFTR is an integral membrane glycoprotein that belongs to the ATP-Binding Cassette 
(ABC) superfamily and is encoded by the CFTR gene (Riordan et al., 1989). The CFTR gene is 
highly conserved across different species highlighting its physiological significance. CFTR is 
responsible for chloride (Cl-) and bicarbonate transport across the membrane (Hwang & Kirk, 
2013). Additionally, there is growing evidence indicating that CFTR regulates the activity of a 
variety of channels (e.g., sodium-potassium chloride cotransporter 1 (NKCC1), epithelial sodium 
channel (eNaC), and anoctamin-1 channel (ANO1) through direct or indirect interaction expanding 
the role of CFTR in preserving osmotic and ionic homeostasis (Berdiev et al., 2009; Kunzelmann, 
2003; Lérias et al., 2018; Lubamba et al., 2012; Shumaker & Soleimani, 1999). 
CFTR consists of two transmembrane domains, each containing six transmembrane alpha-
helices and an intracellular nucleotide-binding domain (NBD). The two domains are linked by a 
regulatory domain that contains a variety of phosphorylation sites for protein kinase A (PKA), and 
protein kinase C (PKC) (Figure 1.1). Phosphorylation of the regulatory domain in conjunction 
with adenosine triphosphate (ATP) hydrolysis at the NBDs appears to favour an open 
conformation and increased affinity to Cl- (Cutting et al., 2019; Hwang & Kirk, 2013; Lubamba et 
al., 2012).  
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Figure 1.1. The CFTR channel. The CFTR channel is a membrane glycoprotein composed of 
two transmembrane domains. Each domain is attached to a nucleotide-binding domain (NBD) that 
binds to ATP and regulates channel opening. In addition, a regulatory domain (R) links both 
transmembrane domains and serves as a phosphorylation site for protein kinase A (PKA) and C 










1.1.2. Peripheral Neuropathy in CF  
With a projected survival rate of approximately 52.1 years (Cystic Fibrosis Foundation, 2018), 
CF patients are exposed to previously unknown chronic complications of the CF pathology. 
Peripheral neuropathy is one of the most relevant extrapulmonary pathologies and significantly 
impacts the quality of life of adult CF patients (Cavalier & Gambetti, 1981; O’Riordan et al., 
1995).  
Peripheral neuropathy involves the aberrant function of sensory, motor, and autonomic nerves 
(Yagihashi et al., 2011). From the cellular perspective, peripheral neuropathy has been studied 
mostly in ion channels, receptors, and signaling pathways associated with cations (Belmonte & 
Viana, 2008; Campbell & Meyer, 2006; Lai et al., 2004; Naziroǧlu et al., 2012; Tomlinson & 
Gardiner, 2008; Wilke et al., 2020). However, evidence shows that alterations in Cl- homeostasis 
can also play a critical role in the regulation of neuronal excitability and the development of 
peripheral neuropathy (Funk et al., 2008; Lorenzo et al., 2020; Morales-Aza et al., 2004; Sung et 
al ., 2000; Wilke et al., 2020). This is a relevant subject of research in the context of peripheral 
neuropathy in CF; On one hand, CFTR is itself permeable to Cl- ions, and on the other, it regulates 
surface expression of Cl- transporters that are responsible for setting the intracellular levels of Cl- 
in peripheral neurons (see section 1.2.1). Thus, CFTR function may be directly linked to both Cl- 
homeostasis and changes in neuronal excitability.  
A variety of clinical, epidemiological, and animal studies support the idea that a lack of 
functional CFTR expression may be relevant to the pathogenesis of peripheral neuropathy. First, 
CFTR is expressed in dorsal root, sympathetic, and paracervical ganglia (Niu et al., 2009; Su et 
al., 2010). Second, reports from CF patients show reduced conduction velocity in both motor and 
sensory nerves (Chakrabarty et al., 2013; O’Riordan et al., 1995). Third, CF patients express 
clinical and subclinical signs of autonomic dysfunction including abnormal adrenergic and 
cholinergic responses in the pupil, sweat glands, and the cardiovascular system. These 
abnormalities are also present in asymptomatic individuals with partial CFTR function, which 
suggests that they are indeed the result of autonomic neuropathy rather than a secondary 
complication of CF (Davis & Kaliner, 1983; Niu et al., 2009; Rubin et al., 1963; Sibinga & 
Barbero, 1961; Sullivan et al., 1986). Fourth, autopsies from CF patients show significant axonal 
dystrophy of the central branch of large primary and secondary afferent neurons in the nucleus 
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gracilis and cuneatus of the brainstem dorsal columns. Interestingly, the degree of axonal 
dystrophy was correlated with the length of survival of the patient (Cavalier & Gambetti, 1981; 
Sung, 1964). Finally, CFTR-/- swine have symptoms of peripheral neuropathy at birth, which 
correlates with loss of Schwann cell function and reduced conduction velocities of trigeminal and 
sciatic nerves (Reznikov et al., 2013). 
Because the nervous system controls and tunes all systemic organ functions, the occurrence of 
peripheral neuropathy in CF patients underscores its possible contribution to the multisystem 
complications linked to the CF pathology (Reznikov, 2017). In sensory neuropathy, sensory 
neurons trigger local inflammatory cascades that could contribute to inflammation in the CF 
pathology (Balestrini et al., 2021; Barnes, 2003; Pisi et al., 2009). Primary sensory neurons are 
known to play vital roles in the gastrointestinal (GI) tract. They provide extrinsic modulation of 
GI motility, locally as well as through relay stations in the spinal cord (Smith-Edwards et al., 
2019). Thus, the occurrence of sensory neuropathy in CF may contribute to the development of GI 
dysmotility and GI-related complications characteristic of CF. Evidence supporting these ideas 
come from diseases also associated with damage of sensory fibers, such as diabetes mellitus, in 
which patients develop GI complications and share some symptoms with CF patients (Azpiroz & 
Malagelada, 2016). Therefore, this project aims to investigate the cellular mechanisms that may 
lead to the development of sensory abnormalities in CF. 
 
1.2.Primary afferent neurons  
Primary afferent neurons are responsible for transducing and transmitting a vast range of 
sensory information from the periphery or the viscera to the CNS (Lai et al., 2004). In vertebrates, 
primary afferent neurons are located in dorsal root ganglia (DRG), trigeminal ganglia, or the 
nodose/jugular complex (Nascimento et al., 2018).  
DRG neurons are pseudo-unipolar (i.e., they have one process protruding from the cell body 
which bifurcates into the peripheral and central branches). The DRG peripheral branch travels in 
parallel with the ventral roots arising from motor neurons in the spinal cord to form 31 pairs of 
spinal nerves that innervate skin, muscles, and internal organs (Haberberger et al., 2019; Zhang et 
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al., 2015). Conversely, the DRG central branch enters the spinal cord through the intervertebral 
foramen to synapse with secondary sensory neurons in the CNS (Marani, 2014).  
DRG neurons are considered a very heterogeneous population (Lai et al., 2004), and they 
generate a variety of sensory fibers. These primary afferent fibers are usually classified according 
to their diameter and conduction velocity. Thus, there are four groups of afferent fibers: large 
diameter myelinated fibers (Aα), medium diameter myelinated fibers (Aβ), small diameter 
myelinated fibers (Aδ), and non-myelinated fibers (C). Aα and Aβ fibers are responsible for 
conveying proprioceptive and mechanosensory information, while Aδ and C fibers are responsible 
for relaying nociceptive information (Duce & Keen, 1977; Harper & Lawson, 1985a, 1985b; Lai 
et al., 2004). In terms of their anatomical organization, the first site of synapse and the ascending 
pathway, both in the CNS, also varies according to the type of DRG neuron. Aδ and C fibers 
typically synapse with dorsal horn neurons (DHN) at laminae II (substantia gelatinosa). The 
ascending processes of the DHNs travel contralaterally along the spinothalamic tract towards the 
thalamus (i.e., spinothalamic pathway). On the other hand, the central process of Aα and Aβ fibers 
will ascend ipsilaterally through the dorsal column and synapse with secondary neurons at the 
nucleus gracilis or the nucleus cuneatus internus of the brainstem. From there, secondary neurons 
will travel contralaterally to convey information to the thalamus (i.e., dorsal column-medial 
lemniscal pathway). All sensory information will be relayed to the thalamus and then projected to 
the somatosensory cortex (Bear, 2016; Løseth et al., 2021; Marani, 2014) (Figure 1.3A). 
Traditionally, secondary sensory neurons were considered the first filtering point for sensory 
information, before reaching the higher sensory regions of the brain. However, the fact that DRG 
neurons express the receptors for the major regulatory neurotransmitters (i.e., ϒ-aminobutyric acid 
(GABA), glutamate) suggests that they may act as an earlier filtering point for sensory information 
(Du et al., 2017). Moreover, the inhibitory effect of Cl- fluxes through GABAA receptors seem to 
play an essential role in the filtering of sensory information at the level of the DRG (see section 
1.3) (Du et al., 2017). 
 
1.2.1. Cl- homeostasis in DRG neurons  
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In the nervous system, intracellular Cl- levels ([Cl-]i) are mainly regulated by the action of two 
cation Cl- cotransporters (CCC): the potassium Cl- cotransporter-2 (KCC2) and NKCC1. KCC2 is 
responsible for the efflux of Cl- while NKCC1 mediates its influx (Wilke et al., 2020). 
Changes in the expression levels of these transporters during development are responsible for 
the “developmental shift” of Cl- homeostasis in the CNS, resulting in a drastic decrease of the [Cl-
]i after birth (Mao et al., 2012). At first, the high functional expression of NKCC1 causes the 
intracellular accumulation of Cl-, which upon activation of GABAA receptors result in depolarizing 
Cl- currents. However, in the adult brain active extrusion of Cl- through KCC2 outweighs the 
activity of NKCC1 resulting in net outward hyperpolarizing Cl- currents and acute inhibition 
(Dzhala et al., 2005).  
In contrast to the maturation process that occurs in CNS neurons, DRG neurons undergo a 
rather subtle developmental transition in [Cl-]i in which there is no reversion in the polarity of Cl- 
currents. In the peripheral nervous system, the low or lack of expression of KCC2 prevents the 
shift in Cl- concentration as described in mature central neurons (Funk et al., 2008; Gilbert et al., 
2007; Mao et al., 2012). These differences between the regulation of Cl- homeostasis in the central 
and peripheral nervous systems is of significant relevance since an increase in the membrane 
conductance for Cl-, such as when GABAA receptors get activated, will have different effects in 
DRG neurons compared to central neurons. However, it is worth mentioning that the depolarizing 
effect of GABA in the PNS is still inhibitory since it contributes to sodium channel inactivation 
and shunting electrical propagation of signals (i.e., decrease in membrane resistance and sodium 
driving force)(Du et al., 2017; Zeilhofer et al., 2012) (Figure 1.2). 
Nevertheless, Cl- homeostasis in DRG neurons is subject to regulation and is a relevant topic 
in the investigation of sensory pathology due to the significance of the electrochemical gradient of 




Figure 1.2. GABA-mediated inhibition of action potential propagation at the level of the 
DRG. Activation of GABAA receptors in DRG neurons promotes the depolarization of the 
membrane through the efflux of Cl- resulting in a voltage-dependent inactivation of sodium 
channels and a decrease in membrane resistance. This will decrease action potential propagation 
along the axon, and the release of excitatory neurotransmitters at the central terminal of the DRG 










1.3. GABA  
GABA is considered the main inhibitory neurotransmitter in the nervous system. The synthesis 
of GABA is catalyzed by the enzyme glutamate decarboxylase 65 and 67 (GAD65 and GAD67). 
There are two major GABA receptors expressed in DRG neurons: GABAA and GABAB receptors. 
The GABAA receptor is a ligand-gated ion channel that mediates the flux of Cl- across the 
membrane (Wu & Sun, 2015). The structure of the GABAA receptor in humans is characterized 
by a heteropentameric conformation composed of different permutations of eight different subunits 
(α(1-6), β (1-3), ϒ(1-3), ρ(1–3), δ, ε, ϴ, and π) with binding sites for GABA, benzodiazepines, 
barbiturates, and neurosteroids (Sigel & Steinmann, 2012; Treiman, 2001). The most common 
isoform in the peripheral nervous system consists of two α1, two β2, and one ϒ2 subunit (Sigel & 
Steinmann, 2012). Conversely, the GABAB receptor is a metabotropic G protein-coupled receptor 
that mediates slow inhibitory effects through attenuation of calcium currents and augmentation of 
potassium currents at the central branch of DRG neurons (Towers et al., 2000).  
Generally speaking, GABA-mediated inhibition of DRG neurons occurs at two different 
levels: the central branch and the soma (Du et al., 2017; Løseth et al., 2021). The inhibitory 
mechanisms at the central branch involve neurons in the rostral ventral medulla (RVM) and 
periaqueductal gray (PAG), which give rise to descending pathways that are essential in the 
modulation of pain. Previously it was thought that these pathways mediated antinociceptive effects 
solely through the release of GABA and enkephalins onto DH neurons of the spinal cord. However, 
evidence indicates that these neurotransmitters are also released onto the central branch of DRG 
neurons. Moreover, inhibition of these descending pathways results in behavioural 
hypersensitivity to heat, suggesting that GABA released from the brainstem is required to suppress 
pain under physiological conditions (Løseth et al., 2021; Zhang et al., 2015) (Figure 1.3B). In 
addition to the descending pathways from the brainstem, there are also local GABAergic 
interneurons in the spinal cord that establish axo-axonic synapses with the DRG neurons. GABA 
from neurons in the brainstem and the spinal cord induces presynaptic inhibition at the DRG and 
reduces the release of excitatory neurotransmitters such as substance P and glutamate (Campbell 
& Meyer, 2006; Moore et al., 2002).  
It was previously accepted that the GABAA receptors highly expressed in the soma of DRG 
neurons were a by-product of receptor trafficking to the DRG central branch, and that they did not 
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have any physiological relevance on neuronal excitability, particularly since there was no 
GABAergic input from the CNS onto the DRG (Du et al., 2017; Fukuoka et al., 1998; Ma et al., 
1993). However, recent evidence shows that there is a local GABAergic system at the DRG that 
is maintained by subpopulations of neurons that release GABA upon stimulation. (Du et al., 2017). 
First, DRG neurons express GAD65 and GAD67 meaning that they have the molecular machinery 
for the synthesis of GABA. Second, DRG neurons express the vesicular GABA transporter 
(VGAT) required to pack GABA into vesicles and various isoforms of the GABA transporter 
(GAT) required for the extracellular removal of GABA, a function also supported by satellite cells 
withing the DRG (Du et al., 2017; Schon & Kelly, 1974).  Third, sniffing patch-clamp experiments 
demonstrate that there is somatic release of GABA at the DRG. Finally, in vitro, and in vivo 
experiments indicate that somatic activation of GABAA receptors impedes the propagation of 





Figure 1.3. Ascending and descending pathways in the sensory nervous system. (A) 
Ascending sensory pathways. In the spinothalamic pathway (Purple line), primary sensory neurons 
will synapse immediately with secondary sensory neurons (aka DHNs) in the spinal cord. The 
axon of secondary sensory neurons will decussate and ascend through the spinothalamic tract 
towards the thalamus. On the other hand, in the dorsal column-medial lemniscal pathway (Blue), 
the central branch of primary sensory neurons will ascend towards the medulla and synapse with 
secondary sensory neurons at the dorsal column nuclei, which consist of the nucleus gracilis and 
the nucleus cuneatus. From there secondary neurons will decussate and synapse with neurons in 
the thalamus. Neurons from the thalamus then project towards the somatosensory cortex. (B) 
Descending sensory modulatory pathways. Neurons from the periaqueductal gray (PAG) receive 
input from higher sensory regions of the brain. PAG neurons project towards the rostral 
ventromedial medulla (RVM) in the brainstem, which contain neurons that mediate the release of 




1.3.1. The GABAergic system and sensory neuropathy  
GABA is an essential modulator of neuronal excitability at different levels of the sensory 
nervous system. Therefore, abnormal GABAergic function has been implicated in the development 
of sensory neuropathy.  
For instance, in the CNS, peripheral nerve injury (PNI) of the sciatic nerve causes increased 
excitability of DHNs and neuropathic pain. The latter is associated with a decrease in the number 
of GABAergic synapses at the level of the DHNs and a switch in Cl- homeostasis mediated by 
brain-derived neurotrophic factor (BDNF) that causes depolarizing GABA responses instead of 
the typical hyperpolarization (Coull et al., 2003; Lorenzo et al., 2020).  
Similarly, sensory abnormalities have been linked with dysregulation of the GABAergic 
system and abnormal concentration of Cl- at the level of the DRG neurons. For example, PNI and 
chronic constriction injury (CCI) are correlated with decreased expression of GABAA receptors in 
DRG neurons (Fukuoka et al., 1998; Obata et al., 2003). Additionally, Funk and colleagues showed 
that exposure to inflammatory mediators results in accumulation of [Cl-]i in DRG neurons 
suggesting a possible Cl- dependent mechanism for the generation of inflammatory hyperalgesia 
and increased neuronal excitability (Funk et al., 2008). This seems to be a direct consequence of 
increased expression of NKCC1 and reduced expression of KCC2 (Funk et al., 2008; Morales-Aza 
et al., 2004). Moreover, electrophysiological experiments indicate that DRG neurons from NKCC1 
mutant mice have abnormal GABA-evoked currents that result from depletion of [Cl-]i. 
Furthermore, behavioural tests in these mice suggest that they have a higher pain threshold 
compared to control mice (Sung et al., 2000). All of the above demonstrates that GABA-mediated 
signaling is an essential modulatory mechanism at the level of DRG, and abnormal expression of 
Cl- transporters may contribute to the development of sensory abnormalities.  
To the best of our knowledge, there are no studies to date that have investigated the relevance 
of CFTR in Cl- homeostasis in the DRG neurons. However, multiple studies in other cell types 
showed that under physiological conditions, CFTR regulates the expression and activity of a 
variety of other transporters that are important in Cl- homeostasis in DRG neurons (Ostroumov et 
al., 2007). For instance, CFTR directly upregulates the expression of NKCC1 (Adam et al., 2005; 
Shumaker & Soleimani, 1999). In terms of the nervous system, Ostroumov and colleagues reported 
that the expression of NKCC1 and CFTR function were positively correlated in motor neurons of 
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the spinal cord (Ostroumov et al., 2011). Additionally, acute inhibition of CFTR in the same 
neurons results in an immediate decrease in the [Cl-]i and a negative shift in the ECl. This, in 
conjunction with the fact that CFTR directly upregulates the expression of NKCC1 in other tissues, 
suggests that CFTR is also required to maintain normal expression of NKCC1 in the nervous 
system (Ostroumov et al., 2011; Shumaker & Soleimani, 1999). Moreover, CFTR inhibits 
amiloride-sensitive sodium channels, which are highly expressed in DRG neurons and are referred 
to as the mammalian brain sodium channels (BNaCs) (Berdiev et al., 2009; García-Añoveros et 
al., 2001; König et al., 2001). In the absence of CFTR, increased activity of BNaC would result in 
intracellular sodium loading and a subsequent reduction in the electrochemical gradient of sodium. 
This will indirectly reduce secondary active transport of Cl- across the membrane through the 
NKCC1 transporter (Adam et al., 2005; A. Ostroumov et al., 2011). Taken together, all of the 
above suggests that CFTR acts as an important regulator of NKCC1. Moreover, since NKCC1 is 
the main Cl- cotransporter in the periphery, CFTR dysfunction may result in significant alterations 
of Cl- homeostasis in DRG neurons.  
Therefore, in the current thesis, we will explore the effect of GABA and Cl- homeostasis in the 
context of sensory abnormalities in an animal model of CF which lacks expression of CFTR.  
 
1.4. Rationale, hypothesis, and experimental objectives 
Previously, CF was considered a pediatric disease, but with improvements in early specialized 
care and management, the median age of survival has increased over time (Elborn, 2016; Lubamba 
et al., 2012). Thus, adult patients are more likely to experience chronic complications of CF. 
Peripheral neuropathy has been identified as a chronic complication of CF, and it has been 
associated with higher chronological age. Furthermore, considering the broad regulatory function 
of the nervous system, peripheral neuropathy may also contribute to the development of other CF 
complications such as GI tract disorders (Cavalier & Gambetti, 1981; O’Riordan et al., 1995; Park, 
1981; Reznikov, 2017).  
So far, the mechanisms underlying peripheral neuropathy in CF have not been explored. 
Nevertheless, the fact that CFTR is expressed in the PNS (Niu et al., 2009; Su et al., 2010) and 
peripheral neuropathy is present in CF patients and animal models of the disease (Cavalier & 
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Gambetti, 1981; Chakrabarty et al., 2013; O’Riordan et al., 1995; Reznikov et al., 2013; J. H. Sung, 
1964) suggests that CFTR might be more important in the PNS than previously considered.  
Furthermore, other reports showed that sensory neuropathy is associated with dysregulation of 
Cl- homeostasis in DRG neurons (Funk et al., 2008) and that CFTR actively modulates functional 
expression of NKCC1 and Cl- homeostasis in spinal motor neurons (Adam et al., 2005; Ostroumov 
et al., 2011; Shumaker & Soleimani, 1999). Changes in Cl- homeostasis have also been linked to 
the dysregulation of the GABAergic system and abnormal excitability of DRG neurons (Sung et 
al., 2000). Therefore, we hypothesized that lack of CFTR expression leads to the dysregulation of 
Cl- homeostasis in sensory neurons, which in turn causes abnormal excitability.  
To test this hypothesis, we will concentrate on the following experimental objectives: 
1.4.i Determination of intracellular chloride concentrations and ECl in DRG neurons from wild 
type and CFTR -/- swine. 
1.4.ii. Effect of pharmacological inhibition of CFTR on DRG neuron excitability. 















MATERIALS AND METHODS  
2.1. Animals  
All experiments were approved by the University of Saskatchewan´s Animal and Research 
Ethics Board and adhere to the Canadian Council of Animal Care guidelines for humane animal 
use.  
We used neonatal swine, wild type, or CFTR knock-out (CFTR-/-), at postnatal day 0 (P0) or 
day 7 (P7). Wild-type swine were obtained from the Prairie Swine Center (University of 
Saskatchewan) and served as controls. Gut-corrected CFTR-/- swine were purchased from 
Exemplar Genetics (Iowa, USA). Gut correction involves partial expression of CFTR in the 
intestine through transfection of the porcine CFTR (pCFTR) gene so that is under the control of 
the intestinal fatty acid-binding protein (iFABP) promoter. Gut correction is required since 100% 
of CFTR -/- piglets develop meconium ileus requiring surgery for survival. Gut corrected swine 
express approximately 20% of the normal level of CFTR in gut epithelia (not in the nervous system 
or muscle tissues), which is sufficient to alleviate meconium (Stoltz et al., 2013). 
 
2.2. Primary lumbar DRG cultures  
The methods to generate lumbar DRG primary cultures are a modified version from a previous 
protocol used in neonatal mice models (Lam et al., 2018). Lumbar (L1-L5) DRGs from neonatal 
swine (P0 or P7) were used for culture. The extraction of the vertebral column was performed 
through two parallel incisions at the level of the iliac crest and the inferior vertebrae of the thoracic 
region. The vertebral column was immediately submerged in cold phosphate-buffered saline (PBS) 
solution. Lumbar DRGs were dissected in a sterile environment and kept submerged in Dulbecco`s 
Modified Eagle Medium (DMEM) containing sodium bicarbonate. DRGs were digested with 0.1% 
collagenase (180-200 U/mL; Worthington, Freehold, NJ) in DMEM containing HEPES (N-2-
hydroxyethylpiperazine-N'-2-rthanesulfonic Acid) (pH: 7.4) at 37ºC for 1 hour in a water bath. 
Next, the ganglia were washed and digested in 0.1% trypsin (180-200 U/mL; Worthington, 
Freehold, NJ). After digestion, DRGs were mechanically dissociated with a fire-polished pipette 
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until the solution had a cloudy appearance, and enzymes were inactivated using the same volume 
of serum-containing media. Cells were precipitated by centrifugation and resuspended in growth 
media containing DMEM-sodium bicarbonate and supplemented with nutrients, horse serum, 
antibiotics (penicillin-streptomycin), and nerve growth factor (10 ng/mL). Then, neurons were 
plated on laminin-coated glass-bottom Petri dishes (35 mm) made in-house. The cultures were 
maintained at 37ºC in a 95% air/ 5% CO2 environment and fed every five days with fresh growth 
media. To eliminate non-neuronal cells, cultures were treated with cytosine arabinoside (ARA-C; 
10µM) from days 2 to 4. Finally, cultures were treated with either vehicle (Dimethylsulfoxide 
(DMSO)) or the CFTR inhibitor 172 (CFTRinh-172), a selective inhibitor that prevents chloride 
flux through CFTR by stabilizing the closed conformation of the channel (Verkman et al., 2013). 
 
2.3. Quantification of Cl- levels in live cells  
 
2.3.1. N-Ethoxycarbonylmethyl-6-methoxyquinolinium bromide (MQAE) 
The intracellular concentration of Cl- was examined using the Cl--sensitive dye N-
ethoxycarbonylmethyl-6-methoxyquinolinium bromide (MQAE). Cultures were incubated at 37ºC 
for two hours with 5 mM MQAE dissolved in growth media. Next, cultures were washed three 
times with an extracellular solution and imaged in an inverted microscope (Axio observer, Carl 
Zeiss, Oberkochen, Germany) under continuous perfusion. The excitation wavelength used was 
470 nm (Colibri 2.0 LED illumination system (Zeiss)) and collected at 510-550 nm wavelength 
emissions with an AxioCam camera (Zeiss) controlled by Zen software (Zeiss). The intracellular 
fluorescence intensity (excluding the nucleus) was subtracted from the background fluorescence. 
The mean MQAE fluorescence intensity, which is inversely proportional to the intracellular levels 
of Cl-, was quantified in WT and CFTR-/- cultures (Kaneko et al., 2002).  
 
2.3.2. Determination of [Cl-]i and equilibrium potential of Cl- (ECl)  
Calibration of the intracellular MQAE fluorescence intensity was done using a double 
ionophore technique (Myung et al., 2015) and the Stern-Volmer Equation (Eq.2.1 and 2.2) 
(Kaneko et al., 2002; Krapf et al., 1988; Myung et al., 2015). 
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= 1 + 𝐾 [𝐶𝑙 ] …………………………….……..(2.1) 
[𝐶𝑙 ] = ……………………….…………..……(2.2) 
Where τ0, is the fluorescence in the absence of Cl-; τ, is the fluorescence intensity in the 
presence of Cl-; Ksv, is the Stern-Volmer quenching constant for Cl-.  
First, cells were incubated with MQAE for two hours as described above. To determine the 
mean fluorescence intensity at a zero-quencher concentration (τ0) the cells were subsequently 
incubated for 30 minutes in a 0 mM Cl- solution containing the ionophores nigericin (which enables 
K+/H+ exchange; 100 mM) and tributyltin (which enables Cl-/OH- exchange; 100 mM). Second, 
cells were incubated in standard solutions to determine the fluorescence intensity (τ) at different 
concentrations (50 mM and 100 mM). Third, using the Stern-Volmer relationship and linear fitting, 
the quenching rate coefficient (KSV) was estimated to be 17.6 M-1. Fourth, the [Cl-]i in each group 
was determined using their respective ratio of fluorescent intensity (τ0/τ) and a rearranged version 
of the Stern-Volmer equation (Eq.2.2). Finally, the equilibrium potential of Cl- (ECl) in each group 





Where R, is the universal gas constant (8.314 JK-1 mol-1); T, is the temperature (298.15 K 
(25ºC); Z, is the valence of Cl- (-1); F, is the Faraday constant (96,485.340 C mol-1); [Cl-], is the 
intracellular (in) and extracellular (out) concentration of Cl-. 
 
2.4.Patch Clamp Electrophysiology  
Recordings were generated under the gramicidin-perforated patch version of the whole-cell 
patch-clamp configuration to keep the intracellular Cl- concentration undisturbed during 
experiments. Gramicidin generates membrane pores impermeable to anions, preserving the normal 
[Cl-]i (Kaneko et al., 2002). A stock solution of gramicidin (50 mg/mL of DMSO) was prepared 
every 2 days and stored at -20ºC. The final concentration of gramicidin in the intracellular solution 
was 100 µg/mL. To improve solubility, the gramicidin solution was warmed for 7 minutes in a 
water bath and sonicated for 10 minutes. The solution was replaced every 2 hours. To facilitate the 
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giga-seal formation, the tip of the electrode was dipped in intracellular fluid (ICF) for 2 seconds 
and then backfilled with gramicidin containing ICF (Ishibashi et al., 2012).  
To assess the formation of gramicidin pores, we monitored access resistance (Ra) and the 
generation of voltage-gated currents. Patch perforation usually occurred between 15 and 30 
minutes. At the end of each experiment, further confirmation of perforated patch configuration 
was achieved by applying negative pressure and obtaining the whole-cell configuration (Ishibashi 
et al., 2012). 
Patch pipettes were made from borosilicate glass (World Precision Instruments, Sarasota, FL, 
USA) using a vertical puller (PC10; Narishige Scientific Instruments, Sarasota, Fl, USA) with a 
resistance of 5-10 MΩ when filled with ICF solution. Micropipettes were filled with the following 
intracellular solution (in mM): 130 KCl, 5 NaCl, 1 MgCl2, 1 CaCl2, 10 HEPES (N-2-
hydroxyethylpiperazineN'-2-ethanesulfonic acid), 10 EGTA (ethylene glycol-bis(2-aminoethyl 
ether)-N,N,N’,N’- tetraacetic acid) and 2 Mg-ATP (adenosine 5'-triphosphate magnesium salt), 
and pH was adjusted to 7.2 with KOH (all from Sigma–Aldrich). Cultured neurons were perfused 
continuously at 2 mL/min with extracellular fluid (ECF) consisting of (in mM): 140 NaCl, 5.4 
KCl, 0.33 NaH2PO4, 0.44 KH2PO4, 2.8 CaCl2, 1 MgCl2, 10 HEPES, 5.0 glucose (all from Sigma-
Aldrich); pH was adjusted to 7.4 with NaOH. . A fast-step perfusion system was used to deliver 
either control or GABA (500 µM; Sigma-Aldrich)-containing extracellular solution at 2 ml/min 
perfusion rate. Membrane currents were recorded at room temperature using an AxoPatch 200B 
amplifier (Molecular, Devices, Palo Alto, CA, USA) equipped with 1 GΩ cooled head stage 
feedback resistor and Digidata 1400A analog to digital converter (Molecular Devices) and stored 
on a personal computer. Voltage-clamp and current-clamp protocols and analysis were performed 
using pClamp 10 (Molecular devices) and Origin 2020 software (Origin Lab Corp., Northampton, 
MA, USA)(Chandna et al., 2015; Lam et al., 2018).  
 
2.4.1. Voltage-clamp electrophysiology: Determination of ECl and [Cl-]i from GABA-evoked 
currents 
Cultured DRG neurons from both genotypes were used in the perforated patch-clamp 
experiments (Ishibashi et al., 2012). Voltage steps (-100 to +100 mV, at 20 mV intervals) were 
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used to evoke GABA currents. The ECl was calculated for each cell by linear regression, and then 
averaged  per age group for each genotype. The [Cl-]i in each group was calculated using a modified 
version of the Nernst equation (Eq. 2.4):  
[𝐶𝑙 ] =
[ ]
    
( /( ) 
  …………………………………..(2.4) 
Where R, is the universal gas constant (8.314 JK-1 mol-1); T, is the temperature (298.15 K 
(25ºC); Z, is the valence of Cl- (-1); F, is the Faraday constant (96,485.340 C mol-1); [Cl-], is the 
intracellular (in) and extracellular (out) concentration of Cl-. 
 
2.4.2. Current-clamp electrophysiology: effect of GABA on DRG neuron excitability  
Primary DRG cultures from WT swine maintained in media containing either vehicle or 
CFTR(inh)-172 (10 µM; Tocris Bioscience; >48 hours) were used in perforated patch-clamp 
experiments (Ishibashi et al., 2012). To determine DRG neuronal excitability, action potentials 
were generated by the injection of depolarizing current steps (100 pA intervals for 500 ms). To 
quantify the inhibitory effect of GABA, action potentials were generated by the injection of a 
depolarizing current ramp from 0 to 0.8 nA (1-second duration) in the presence of control and 
GABA (500 µM; Sigma-Aldrich)-containing extracellular solution.  
 
2.5.Statistical Analysis 
All data are reported as mean ± standard error of the mean (SEM). The equilibrium potential 
of Cl- was calculated from parameters obtained by linear regression.  Two-way ANOVA followed 
by a Tukey´s post hoc test was used to analyze the Cl- imaging, voltage clamp, and current-clamp 
data. A student´s t-test or Mann-Whitney test was employed to analyze the action potential 
frequency within groups for the current-clamp data. In all cases, data with p values less than 0.05 
were considered statistically significant. All statistical analyses were performed using Prism 8 





CHAPTER 3  
RESULTS  
3.1. Determination of intracellular chloride concentrations and ECl in DRG neurons from 
WT and CFTR -/- swine 
 
3.1.1. MQAE live-imaging 
We observed a significant difference in the mean MQAE fluorescence intensity in neurons 
from CFTR-/- piglets relative to those from WT. DRG neurons from CFTR-/- swine had higher 
mean MQAE fluorescence (P0, 82.3±1.24 AU; P7, 83.3±1.3 AU) than neurons from WT swine 
(P0, 63.3±1.1 AU; P7, 67.0±1.2 AU). Since the MQAE fluorescence is inversely proportional to 
the concentration of Cl-, our data indicate that lack of CFTR expression resulted in lower 









Figure 3.1. DRG neurons from CFTR-/- swine displayed higher MQAE fluorescence 
intensity. (A) Representative fluorescent images of cultured DRG neurons incubated with MQAE 
from the following groups: WT P0 (n=1052), WT P7 (n=792) P0 CFTR-/- (n=1195), and P7 
CFTR-/- (n=859). (B) The bar graph summarizes the mean MQAE fluorescence intensity for all 
groups. Data are expressed as the mean ± SEM arbitrary fluorescent units [AU]. Statistical analysis 
was performed by two-way ANOVA followed by a Tukey´s post hoc test; ***p<0.001. ns p-
values: P0 WT vs P7 WT p=0.1551, P0 CFTR-/- vs P7 CFTR-/- p=0.9424. Scale bar in A 













Next, we calculated the [Cl-]i for each group using the MQAE fluorescent data. To calibrate 
the mean MQAE fluorescence intensity we used a double ionophore technique (Myung et al., 
2015) in combination with the Stern-Volmer equation, which allowed us to determine [Cl-]i from 
the kinetic interactions of fluorescent molecules (See Materials and Methods; Figure 3.2A) 
(Kaneko et al., 2002; Myung et al., 2015)  
The calculated [Cl-]i in neurons from P0 (28.4±1.8 mM) and P7 (20.4±1.6 mM) CFTR-/- swine 
was significantly less than those in WT swine (P0, 53.0±2.3 mM; P7, 44.3±2.3 mM) (Figure 3.2B). 
Additionally, we calculated the ECl in each group using the Nernst equation. We found a significant 
negative shift in the calculated ECl of neurons from CFTR-/- swine (P0, -43.4 ±1.6 mV; P7, -51.7 
±1.9 mV) with respect to those from WT swine (P0, -27.3±1.6 mV; P7, -31.9±1.3 mV) (Figure 
3.2C). Thus, our results provide supporting evidence that CFTR is required for the physiological 











Figure 3.2. DRG neurons from CFTR-/- swine had less [Cl-]i and a negatively shifted ECl. (A) 
Determination of [Cl-]i using the Stern-Volmer relationship. The [Cl-]i was extrapolated for the 
following groups: 0 mM (n=325), 50 mM (n=292) and 100 mM(n=227) using a conventional linear 
fit. Collected results yielded a Ksv of 17.6 M-1 (B) Mean intracellular Cl- concentration in WTP0, 
WTP7, CFP0, and CFP7 cells. (C) The calculated mean ECl for each group (see Materials and 
Methods). Data are expressed as the mean ± SEM. Statistical analysis performed by two-way 
ANOVA followed a Tukey´s post hoc test; *p<0.05, **p<0.01, ***p<0.001. (C) ns p-values: P0 













3.1.2. Gramicidin-perforated patch-clamp electrophysiology  
First, we determined the mean passive membrane properties for all groups (WTP0, WTP7, 
CFTR-/- P0, and CFTR-/- P7) as reported in Table 3.1. We did not find any significant differences 






















Table 3.1. Passive membrane properties of WT and CFTR -/- DRG neurons from P0 and P7 
swine. Data are expressed as the mean ± SEM. Statistical analysis was performed by two-way 
ANOVA followed by a Tukey´s post hoc test. Cm, membrane capacitance (pF); Vm, membrane 
potential (mV); n, number of cells tested. ns p-values (Cm): P0 WT vs P7 WT p=0.6679, P0 CFTR-
/- vs P7 CFTR-/- p=0.9598, P0 WT vs P0 CFTR-/- p=0.9998, P7 WT vs P7 CFTR-/- p=0.9642. ns 
p-values (Vm): P0 WT vs P7 WT p=0.9298, P0 CFTR-/- vs P7 CFTR-/- p=0.9665, P0 WT vs P0 














 Cm(pF) Vm(mV) n 
WT P0 23.11±4.22 -61.96±1.94 17 
CFTR -/- P0 22.60±2.70 -64.98±1.75 12 
WT P7 29.47±4.67 -63.48±1.85 19 
CFTR -/- P7 26.25±4.65 -63.44±2.36 9 
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Next, to provide further evidence supporting our hypothesis that CFTR is required to maintain 
physiological Cl- levels in DRG neurons, we determined the ECl in DRG neurons from WT and 
CFTR -/- swine using gramicidin-perforated patch-clamp electrophysiology and GABA evoked 
currents (Figure 3.3A). 
Consistent with the available literature, our results suggest that the mean ECl in DRG neurons 
is highly heterogenous, ranging from -60 to -20 mV, which corresponds to [Cl-]i from 10 to 80 mM 
(Gilbert et al., 2007; Wilke et al., 2020). Using GABA-evoked currents at different test potentials 
(-100 to +20 mV, for 3000 ms) we plotted the current-voltage (IV) relationship and calculated the 
ECl per cell, which was then used to estimate the mean per group. (Figure 3.3B-D). We found no 
significant differences in the mean ECl of DRG neurons from P0 (-19.7±1.3 mV) and P7 (-20.6±2.1 
mV) CFTR-/- swine compared to neurons from P0 (-25.0 ±0.9 mV) and P7 (-27.1±0.8 mV) WT 
swine. Additionally, and contrasting with our live-imaging [Cl-]i calculations, when we used a 
rearranged form of the Nernst equation (Figure 3.3E) to calculate the [Cl-]i from GABA-evoked 




Figure 3.3. Gramicidin-perforated patch-clamp recordings indicate that DRG neurons from 
CFTR-/- swine have similar ECl compared to WT swine. (A) Sample current trace from 
perforated patch configuration experiments, in which currents were evoked by the application of 
GABA at different step voltages (-100 to +20 mV, at 20 mV intervals). (B) Individual ECl, (C) 
representative Current vs Voltage (I-V) relationship (D) average ECl for WT and CFTR-/- DRG 
neurons from P0 (WT, n=17; CFTR-/-, n=12) and P7 (WT, n=19; CFTR-/-, n=9) swine. Data are 
expressed as the mean ± SEM. Statistical analysis was performed by two-way ANOVA followed 
by a Tukey´s post hoc test. Inset in A represents the stimulation protocol. (D) ns p-values: P0 WT 
vs P7 WT p=0.8666, P0 CFTR-/- vs P7 CFTR-/- p=0.9817, P0 WT vs P0 CFTR-/- p=0.3856, P7 
WT vs P7 CFTR-/- p=0.7713. (E) ns p-values: P0 WT vs P7 WT p=0.6029, P0 CFTR-/- vs P7 




3.2.Pharmacological inhibition of CFTR had no effect on DRG neuron excitability 
First, we determined the mean passive membrane properties of all groups (Vehicle P0, Vehicle 
P7, CFTR(inh)-172 P0, and CFTR(inh)-172 P7) studied as reported in Table 3.2. We did not find 






















 Cm(pF) Vm(mV) n 
WT P0 29.92±3.20 -58.82±5.50 27 
CFTR(inh)-172 P0 34.52±4.29 -61.16±1.53 14 
WT P7 30.48±4.63 -69.93±1.98 14 
CFTR(inh)-172 P7 26.98±3.75 -64.79±2.86 14 
Table 3.2. Passive membrane properties of WT DRG neurons from P0 and P7 swine exposed 
to vehicle and CFTR(inh)-172 . Data are expressed as the mean ± SEM. Statistical analysis 
performed by two-way ANOVA followed by a Tukey´s post hoc test.; Cm, membrane capacitance 
(pF); Vm, membrane potential (mV); n, number of cells tested. ns p-values (Cm): P0 WT vs P7 
WT p=0.9996, P0 CFTR-/- vs P7 CFTR-/- p=0.6068, P0 WT vs P0 CFTR-/- p=0.8233, P7 WT vs 
P7 CFTR-/- p=0.9396. ns p-values (Vm): P0 WT vs P7 WT p=0.3015, P0 CFTR-/- vs P7 CFTR-
















Next, we concentrated on evaluating the role of CFTR on neuronal excitability. Unpublished 
results from our laboratory revealed that DRG neurons from CFTR-/- swine had a significantly 
reduced generation of action potentials (Givzad, 2020). We further explored this effect by using 
the CFTR selective inhibitor, CFTR(inh)-172, and subsequently evaluating neuronal excitability 
in cultured DRG neurons from WT swine. To quantify excitability, we employed current-clamp 
electrophysiology and exposed neurons to depolarizing current steps for 0.5 s, from 0 to 1500 pA 
(at 100 pA intervals), preceded by a hyperpolarizing step to remove partial inactivation of voltage-
gated sodium channels (-300 pA for 0.1s) (Figure 3.4A). Moreover, to avoid disturbances of [Cl-
]i, these experiments were done in the perforated patch-clamp configuration.  
Contrasting with the unpublished results from CFTR-/- swine, we observed no significant 
changes in the action potential firing frequency between P0 and P7 WT DRG neurons treated with 
vehicle and CFTR (inh)-172 (P0 Vehicle= 3.0±0.6 s-1, P7 Vehicle= 3.4±1.2 s-1, P0 CFTR(inh)-






Figure 3.4. DRG neurons from WT swine treated with CFTR (inh)-172 had normal 
excitability. (A) Representative current-clamp traces of DRG neurons from P0 and P7 WT swine 
treated with CFTR(inh)-172 or vehicle. (B) Line graph summarizes action potential firing 
frequency in DRG neurons from P0 and P7 WT swine treated with CFTR(inh)-172 and vehicle. 
(C) The bar graph summarizes the action potential firing frequency at the 1000 pA injection step. 
We observed no significant differences in DRG neurons from P0 and P7 WT swine treated with 
CFTR(inh)-172 and vehicle. P0 Vehicle (n=27), P0 CFTR(inh)-172 (n=14), P7 Vehicle (n=14), 
and P7 CFTR (inh)-172 (n=11). Statistical analysis was performed by two-way ANOVA followed 
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by a Tukey´s post hoc test. ns p-values: P0 Vehicle vs P7 Vehicle p=0.9886, P0 CFTR (inh)-172 
vs P7 CFTR (inh)-172  p=0.5938, P0 Vehicle vs P0 CFTR (inh)-172  p=0.6684, P7 Vehicle vs P7 























3.3.GABA does not modulate DRG neuron excitability in swine 
It has been reported that GABA can decrease action potential frequency in DRG from mice 
(Du et al., 2017). Therefore, considering that our MQAE fluorescence data suggest that lack of 
CFTR impairs Cl- homeostasis in DRG neurons from swine, we next evaluated the effect of GABA 
on action potential frequency in DRG neurons from WT swine incubated with or without 
CFTR(inh)-172 (Figure 3.5A). As described above, we used the perforated patch configuration to 
avoid disturbances in [Cl-]i.  
Similar to our previous findings (see section 3.2), we did not observe a change in action 
potential frequency between WT cells treated with vehicle or the CFTR (inh)-172 (Figure 3.5B). 
As expected, the application of GABA induced a mild depolarization on the DRG resting potential 
(Figure 3.5A, blue trace). However, we did not observe a significant effect of GABA on action 
potential frequency between WT cells treated with vehicle and the CFTR (inh)-172 (Figure 3.5C). 
Therefore, our electrophysiology data suggest that inhibition of CFTR function, and GABA do not 












Figure 3.5. GABA does not affect the action potential firing frequency of DRG neurons. (A) 
Representative current-clamp recording indicates no change in action potential firing frequency 
following GABA application. (B) Action potential firing frequency is similar in P0 and P7 DRG 
neurons treated with CFTR (inh)-172 and vehicle (C) GABA has no significant effect on action 
potential firing frequency in P0 and P7 DRG neurons treated with CFTR (inh)-172 and vehicle. 
Data are expressed as the mean ± SEM. Statistical analysis was performed by a two-way ANOVA 
followed by a Tukey´s post hoc test and Mann-Whitney test. P0 Vehicle (n=14), P0 CFTR (inh)-
172 (n=8), P7 Vehicle (n=9), and P7 CFTR (inh)-172 (n=8). Inset in A represents the stimulation 
protocol. (B) ns p-values : P0 Vehicle vs P7 Vehicle p=0.9963, P0 CFTR (inh)-172 vs P7 CFTR 
(inh)-172  p=0.9967, P0 Vehicle vs P0 CFTR (inh)-172  p=0.8940, P7 Vehicle vs P7 CFTR (inh)-
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172  p=0.9686. (C) ns p-values: P0 Vehicle p=0.6870, P7 Vehicle p=0.8076, P0 CFTR (inh)-172 
























CHAPTER 4  
DISCUSSION  
The association between peripheral neuropathy and CF was first described almost 60 years ago 
by J. H. Sung (Sung, 1964). Since then, epidemiological, clinical, and animal studies demonstrated 
that peripheral neuropathy is an important extrapulmonary complication of CF (Chakrabarty et al., 
2013; Davis & Kaliner, 1983; Niu et al., 2009; O’Riordan et al., 1995; Reznikov et al., 2013; Rubin 
et al., 1963; Sibinga & Barbero, 1961; Sullivan et al., 1986). Originally, peripheral neuropathy was 
considered a secondary complication of malnutrition in CF (Cavalier & Gambetti, 1981). 
However, later studies found that CFTR is highly expressed in the PNS, suggesting that neuropathy 
could result from the functional absence of CFTR in peripheral neurons (Niu et al., 2009; Su et al., 
2010).  
To the best of our knowledge, the involvement of CFTR in the modulation of Cl- homeostasis 
in neurons has only been studied in the CNS. It was reported that CFTR is an important regulator 
of Cl- homeostasis and neuronal excitability in motor neurons in the spinal cord (Ostroumov et al., 
2011). However, whether CFTR plays such a role in peripheral neurons, including sensory 
neurons, remained to be studied and it was the main focus of the current investigation.  
 
4.1. Lack of CFTR expression resulted in reduced [Cl-]i in swine DRG neurons 
In the current thesis, we used two independent methods, live Cl- fluorescence imaging and 
electrophysiology, to investigate whether CFTR contributes to [Cl-]i in DRG neurons of swine. 
Although the results obtained through these two methods were not consistent, we can interpret our 
findings and draw conclusions based on the experimental design and methodological 
considerations.  
Our imaging experiments revealed that lack of CFTR is associated with lower [Cl-]i in swine 
DRG neurons (from both ages tested). Similar results were reported by Ostroumov and 
collaborators in motor neurons from the spinal cord, in which acute inhibition of CFTR caused a 
decrease in [Cl-]i and a negative shift in the ECl (Ostroumov et al., 2011). The change in Cl- levels, 
and its corresponding ECl, that we report in DRG neurons, could be explained by the regulatory 
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interactions of CFTR with other proteins involved in Cl- transport. CFTR increases the expression 
of NKCC1, which is responsible for Cl- accumulation in DRG neurons (Ostroumov et al., 2007; 
Shumaker & Soleimani, 1999). CFTR also downregulates amiloride-sensitive sodium channels 
(i.e., BNaC), which indirectly stimulates the activity of NKCC1 (Adam et al., 2005; A. Ostroumov 
et al., 2011). Thus, lack of CFTR would result in decreased expression and reduced activity of 
NKCC1, leading to depletion of [Cl-]i, and a negative shift of the ECl, as observed in the MQAE 
fluorescence experiments. Consistent with this idea, DRG neurons from NKCC1 knock-out mice 
display reduced Cl- levels and a negative shift in ECl as we observed in CFTR-/- swine. 
Interestingly, the absence of NKCC1 in mice was also associated with a higher pain threshold and 
the development of sensory dysfunction (Sung et al., 2000).  
Contrasting with our MQAE findings, the perforated patch-clamp electrophysiology results 
showed that DRG neurons from WT and CFTR -/- swine had similar [Cl-]i. Although we can not 
provide a conclusive argument of these contrasting effects, we can, however, propose two possible 
explanations: 
1. Lack of current reversibility in patch-clamp experiments: When the Vm of the cell is forced 
to values more positive than the ECl we are supposed to see outward GABA currents, which 
corresponds to Cl- entering the cell. However, in our experiments, we observed an abnormal 
inward rectification of the IV relationship for GABA at membrane potentials more positive than 
the ECl. This deviation from the linearity in the IV relationship prevented the graphical 
determination of the ECl (Figure 3.3C). Additionally, cells with a very negative ECl (e.g., -100, -80 
mV) could not be analyzed due to the lack of current. The latter prevented us from quantifying a 
shift to more negative potentials in the ECl of neurons from CFTR-/- swine, which we were able to 
observe by MQAE fluorescence. Previous studies in DRG neurons from mice (Sung et al., 2000) 
and humans (Valeyev et al., 1996) show that GABA-mediated currents were linearly proportional 
to the driving force of Cl- (Vm-ECl) at any voltage, which indicates no rectification in the IV 
relationship for GABA. However, according to the Goldman-Hodgkin-Katz (GHK) equation, in 
the presence of asymmetrical concentrations of Cl-, the IV plot would follow a non-linear 
relationship since the flow of Cl- would be favoured in one direction compared to the other (Clay, 
2009; O’Toole & Jenkins, 2012). In our case, the fact that we conserved the physiological [Cl-]i 
through perforated patch-clamp experiments could account for the unusual rectification observed 
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in the GABA IV relationship, and thus, for the lack of reversibility of the GABA-evoked currents 
at the Vm>ECl. In future experiments, we plan to generate the IV plot from each cell under both the 
gramicidin-perforated patch configuration, as well as under whole-cell after allowing sufficient 
time (approximately 15 min) for the Cl- concentration to equalize across the membrane. This 
experiment will allow us to determine if the unusual GABA IV relationship reported in this thesis 
was due to GHK rectification.  
2. Bias in the MQAE fluorescence experiments: The MQAE imaging experiments provided a 
robust quantification of Cl- values, due to the combination of a large number and the fact that the 
technique prevents any possible cell damage, as may be induced by patching electrodes. However, 
there are limitations associated with this technique that may affect ECl measurements. Since 
MQAE fluorescence is inversely proportional to the Cl- concentration, the dye would be 
completely quenched in cells with very high [Cl-]i , resulting in dark images. The latter introduces 
a bias of the mean [Cl-]i towards lower concentrations and the ECl toward more negative values.  
Taken together, the limitations inherent to the techniques used introduced bias in the 
determination of [Cl-]i and ECl in the opposite end of the spectrum, which could account for some 
of the discrepancies observed in our results obtained by MQAE fluorescence and patch-clamp 
electrophysiology.  
 
4.2. GABA did not modulate DRG neuron excitability in swine 
To study whether changes in Cl- concentration due to the absence of CFTR could result in 
changes in neuronal excitability and GABA mediated inhibition, we used current clamp 
electrophysiology in the perforated patch-clamp configuration. Unpublished observations from our 
laboratory (Givzad, 2020), showed that DRG neurons from CFTR-/- swine had impaired action 
potential generation. To further study this effect, we used WT DRG neurons from the same ages 
as in the previous study and incubated them in CFTR(inh)-172 conditions. 
However, we observed no significant changes in the action potential firing frequency of WT 
DRG neurons treated with CFTR(inh)-172 when compared to vehicle. The discrepancies in these 
two sets of results from our own research team may be explained by the different developmental 
environments DRG neurons were exposed. In the knock-out swine, DRG neurons developed 
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without CFTR expression, while in the case of WT DRG neurons, CFTR function was only 
inhibited for 48 hr in culture conditions. Furthermore, the effects of inhibiting CFTR function may 
be different from lack of expression of the CFTR protein. The latter could be related to the 
intracellular pathways downstream and regulated by CFTR function, which may play different 
functions in the CFTR-/- swine.  
We hypothesized that DRG neurons incubated with the CFTR(inh)-172 would have abnormal 
GABA mediated inhibition of action potential firing, based on previous reports in mice showing 
that acute inhibition of CFTR in central neurons had significant effects on the [Cl-]i (Ostroumov et 
al., 2011), and that GABA mediated depolarization impeded action potential firing through the 
soma of DRG neurons (Du et al., 2017). However, our findings indicate that GABA did not 
modulate neuronal excitability in swine as it does in rodents. Recent research indicate that there 
are other Cl- channels that closely interact with CFTR and seem to be relevant in regulating DRG 
neuron excitability, such as the calcium-activated cation channel, ANO1, also known as 
Transmembrane member 16A (TMEM16A) (Jin et al., 2013; Lérias et al., 2018). Therefore, for 
future experiments, we will study the relevance of this Cl- channel in the excitability of DRG 
neurons.  
 
4.3. Peripheral Neuropathy and Pathophysiology of CF  
The extent to which peripheral neuropathy contributes to the pathophysiology of CF is 
unknown. However, studies of peripheral neuropathy in other conditions such as diabetes mellitus 
provide some insight into the overall pathological consequences that may arise from impaired 
function of the PNS (Bansal et al., 2006).  
For instance, CF is associated with intestinal dysmotility, constipation, and serious intestinal 
blockages (Rafeeq & Murad, 2017). Primary manifestations of GI dysmotility in CF can occur as 
early as in the neonatal stage (i.e., meconium ileus) or at any age (i.e., distal intestinal obstruction 
syndrome (DIOS) (Ooi & Durie, 2016; Park, 1981). Although this has been widely attributed to 
the lack of functional CFTR in the gut epithelium, the possible contribution of a neurogenic 
component has not yet been studied (Ooi & Durie, 2016). Two important pieces of evidence 
indicate that peripheral neuropathy may be more important than previously considered in the 
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development of gut disorders in CF. First, elegant research from Smith-Edwards and collaborators 
found that afferent input from DRG neurons modulates smooth muscle contraction in the colon 
via the activation of a parasympathetic spinal circuit (Smith-Edwards et al., 2019). This suggests 
that sensory neuropathy may impair extrinsic neurogenic control of GI function and contribute to 
the development of GI tract abnormalities in CF. Second, there is substantial evidence that 
peripheral neuropathy in Diabetes mellitus alters intestinal motility, leading to a range of 
abdominal manifestations (e.g., constipation, intestinal distention, and abdominal pain) that share 
some similarities with those present in CF symptomatology (Azpiroz & Malagelada, 2016).  
In CF, the most common and fatal symptom is local inflammation of the lungs. Primarily, 
inflammation of the lungs has been attributed to the mucus retention and chronic infection that 
results from improper airway clearance (Cutting et al., 2019; Elborn, 2016). However, evidence 
indicates that inflammation in CF may also have a neurogenic component (Borson et al., 1989). 
This idea arises from a unique form of retrograde signaling termed neurogenic inflammation, 
which involves the release of inflammatory substances such as substance P and calcitonin-gene-
related peptide (CGRP) from afferent neurons (Willis, 2003). These receptors are widely 
distributed in the human airways and are current targets of investigation for the treatment of asthma 
(Balestrini et al., 2021; Barnes, 2003; Pisi et al., 2009). Moreover, there is evidence that abnormal 
intracellular levels of Cl- can result in the generation of action potentials at the central branch of 
the DRG neurons, which propagate antidromically and potentially stimulate neurogenic 
inflammation in the periphery (Willis, 1999). Therefore, considering the close interaction between 
airway nerves and inflammation together with sensory neuropathy in CF, neurogenic inflammation 
could, at least partially, account for the development of airway pathology in CF.  
 
4.4. Future Directions and Limitations  
Our first limitation is that due to the cost and availability of CFTR -/- swine we could not 
perform all experiments in CFTR-/- DRG neurons. Therefore, we decided to culture WT DRG 
neurons and incubate them in the presence of CFTR(inh)-172. Although this could potentially 
mimic the short-term effects in the [Cl-]i, this method may not reliably account for the long-term 
changes that may result from functional absence of CFTR. In addition, a second limitation is that 
in our voltage-clamp experiments we observed a completely unexpected inward rectification of 
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GABA currents, which prevented the reliable measurement of the ECl at negative voltages. It would 
be interesting in the future to investigate the molecular mechanisms behind inward rectification of 
these channels in swine. 
In addition, the current consensus is that CFTR regulates Cl- homeostasis through direct and 
indirect interactions with other transporters. Although these mechanisms have been previously 
studied in the epithelium (Adam et al., 2005; König et al., 2001; Lérias et al., 2018; Shumaker & 
Soleimani, 1999), there are no studies that investigated the intracellular pathways downstream and 
upstream of CFTR in the nervous system. For instance, the WNK (With no lysine)–SPAK (SPS1-
Related Proline/Alanine rich Kinase) / OSR1 (Oxidative Stress Responsive Kinase 1) complex, 
which is a Cl- sensitive cascade that regulates the activity of NKCC1 and KCC2, could be a 
possible candidate since there is evidence that CFTR closely interacts with this pathway (Huang 
et al., 2019; Kim et al., 2020; Yang et al., 2007). Moreover, dysregulation of the WNK-
SPAK/OSR1 pathway has been postulated as a key contributing factor in the development of 
neurological disorders that are associated with abnormal Cl- homeostasis (Alessi et al., 2014; 
Watanabe & Fukuda, 2015). Therefore, taking into account the relevance of CFTR in the 
regulation of NKCC1 expression in other tissues and the possible interaction between CFTR and 
the WNK-SPAK/OSR1 pathway our next objective will be to study the expression levels of these 
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